Cargando…
Intra-tumoral delivery of functional ID4 protein via PCL/maltodextrin nano-particle inhibits prostate cancer growth
ID4, a helix loop helix transcriptional regulator has emerged as a tumor suppressor in prostate cancer. Epigenetic silencing of ID4 promotes prostate cancer whereas ectopic expression in prostate cancer cell lines blocks cancer phenotype. To directly investigate the anti-tumor property, full length...
Autores principales: | Korang-Yeboah, Maxwell, Patel, Divya, Morton, Derrick, Sharma, Pankaj, Gorantla, Yamini, Joshi, Jugal, Nagappan, Perri, Pallaniappan, Ravi, Chaudhary, Jaideep |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5340093/ https://www.ncbi.nlm.nih.gov/pubmed/27487149 http://dx.doi.org/10.18632/oncotarget.10953 |
Ejemplares similares
-
Polycaprolactone/maltodextrin nanocarrier for intracellular drug delivery: formulation, uptake mechanism, internalization kinetics, and subcellular localization
por: Korang-Yeboah, Maxwell, et al.
Publicado: (2015) -
Inactivation of ID4 promotes a CRPC phenotype with constitutive AR activation through FKBP52
por: Joshi, Jugal Bharat, et al.
Publicado: (2017) -
ID4 regulates transcriptional activity of wild type and mutant p53 via K373 acetylation
por: Morton, Derrick J, et al.
Publicado: (2016) -
Id1 and Id3 expression is associated with increasing grade of prostate cancer: Id3 preferentially regulates CDKN1B
por: Sharma, Pankaj, et al.
Publicado: (2012) -
Id4 dependent acetylation restores mutant-p53 transcriptional activity
por: Knowell, Ashley E, et al.
Publicado: (2013)